<DOC>
	<DOC>NCT02037919</DOC>
	<brief_summary>Women who receive Nexplanon immediately post abortion will be significantly more likely to be using the device 6 months after the procedure than those assigned to receive the device 2-4 weeks after the procedure.</brief_summary>
	<brief_title>Nexplanon Application Post-Abortion</brief_title>
	<detailed_description>Women will be contacted 6 months after their abortion to ask about contraception use and side effects.</detailed_description>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>18 years of age and older, an intrauterine pregnancy &gt; 14 weeks and &lt;23 6/7 weeks gestation and desire termination of pregnancy desire a Nexplanon for contraception able to give informed consent in English no contraindications to Nexplanon (based on U.S. CDC Medical Eligibility Criteria for Contraception) or D&amp;E unable to give informed consent have any of the following medical conditions: active venous thromboembolism, known or suspected sexsteroid sensitive malignancies, current hepatic disease with abnormal liver function tests, undiagnosed vaginal bleeding, hypersensitivity to any of the ingredients in Nexplanon. nonsurgical management of pregnancy prior participation in this study breast cancer or a history of breast cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>